NGC Update Service: September 12, 2011
September 12, 2011
New This Week
Guideline Summaries
American Academy of Sleep Medicine
American College of Radiology
- ACR Appropriateness Criteria® anal cancer. This updates a previously published guideline summary.
- ACR Appropriateness Criteria® dementia and movement disorders. This updates a previously published guideline summary.
- ACR Appropriateness Criteria® palpable abdominal mass. This updates a previously published guideline summary.
- ACR Appropriateness Criteria® post-treatment follow-up of prostate cancer. This updates a previously published guideline summary.
- ACR Appropriateness Criteria® suspected liver metastases. This updates a previously published guideline summary.
Centers for Disease Control and Prevention
- (1) U.S. medical eligibility criteria for contraceptive use, 2010: adapted from the World Health Organization medical eligibility criteria for contraceptive use, 4th edition. (2) Update to CDC's U.S. medical eligibility criteria for contraceptive use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period. This is an addendum to a previously published guideline summary.
Emergency Nurses Association
- Family presence during invasive procedures and resuscitation in the emergency department.
- Gastric tube placement verification.
- Needle-related procedural pain in pediatric patients in the emergency department.
- The use of capnography during procedural sedation/analgesia in the emergency department.
U.S. Preventive Services Task Force
- Screening for testicular cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. This updates a previously published guideline summary.
Announcements
NGC Spotlight
Visit the Preventing Hospital-Acquired Conditions page for evidence-based resources available on the NGC Web site to assist users in the prevention of the CMS-identified hospital-acquired conditions.
Conference News
- The 2011 AHRQ Annual Conference, "AHRQ: Leading Through Innovation & Collaboration," will be held September 18-21, 2011 in Bethesda Maryland. In keeping with this year's theme, the event will emphasize how AHRQ is leading change in addressing today's challenges in improving access to care and its quality and cost, as well as partnering with others at the forefront of these issues. Visit the conference home page for more information. Registration is now open.
U.S. Food and Drug Administration (FDA) Advisories
- September 7, 2011: Tumor Necrosis Factor-alpha (TNFα) Blockers): FDA notified healthcare professionals that the Boxed Warning for the entire class of Tumor Necrosis Factor-alpha (TNFα) blockers has been updated to include the risk of infection from two bacterial pathogens, Legionella and Listeria. In addition, the Boxed Warning and Warnings and Precautions sections of the labels have been revised so that they contain consistent information about the risk for serious infections and the associated disease-causing pathogens.
- September 1, 2011: Saphris (asenapine maleate): FDA notified healthcare professionals and patients that serious allergic reactions have been reported with the use of Saphris (asenapine maleate). The Contraindications, Warnings and Precautions, Adverse Reactions, and Patient Counseling Information sections have been revised.
- September 1, 2011: Reclast (zoledronic acid): FDA notified healthcare professionals and patients of an update to the drug label for Reclast (zoledronic acid) regarding the risk of kidney failure. Cases of acute renal failure requiring dialysis or having a fatal outcome following Reclast use have been reported to FDA.
NGC's Sister Resources
- Find Innovations and QualityTools classified by disease or clinical category, patient population, setting of care, stage of care, and more in AHRQ's Health Care Innovations Exchange Web site.
- Look for Quality Measures in AHRQ's National Quality Measures Clearinghouse (NQMC).
0 comments :
Post a Comment